Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in Chi...
Medicilon (688202): Won the procurement project of Shenzhen GeBiJia Molecular Drug Innovation Center Co., Ltd., with a winning amount of 9.1785 million yuan
Medicilon (688202): Won the bid for the procurement project of Zhejiang Provincial Tongde Hospital (Zhejiang Provincial Academy of Traditional Chinese Medicine), with a bid amount of 2.98 million yuan
CIIE Direct Hit: AI Reshapes the Health Ecosystem
Medicilon: Net loss of RMB 16.7865 million in the third quarter
A-share innovative drug concept stocks fluctuated and rose, Wolwo Pharma increased by over 10%, Chemexpress rose by over 9%, Fushine, CSBIO, and Medicilon followed suit
Medicilon: The company has fulfilled its contractual obligations, and Hongxu Biotech has yet to pay the remaining contract amount of 557,600 yuan